Concomitant Azoles Does Not Affect Clinical Outcomes With Ru

Concomitant azoles did not negatively affect efficacy with ruxolitinib or best available therapy in patients with acute graft-versus-host disease.

Related Keywords

San Antonio , Texas , United States , Zahra Mahmoudjafair , University Of Kansas Medical Center , Trial Group , Cellular Therapy , Kansas Medical Center , Concomitant Azoles , Ruxolitinib Treatment , Acute Graft Versus Host Disease , Post Hoc Analysis , Randomized Phase , Cellular Therapy Meetings , Transfus Cell , 2024 Transplantation Amp Cellular Therapy Meetings , Phase 3 Reach2 Study Nct02913261 , Ruxolitinib Jakafi , Graft Vs Host Disease Gvhd ,